Aug 24
|
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
|
Aug 24
|
High demand, low supplies for Novo's weight-loss drug launch in Germany
|
Aug 23
|
Why Novo Nordisk Stock Was Racing Higher on Wednesday
|
Aug 23
|
REFILE-Novo hires Thermo Fisher as 2nd manufacturer for Wegovy weight-loss drug - source
|
Aug 22
|
Could This 1 Problem Put a Dent in Novo Nordisk and Eli Lilly Stock?
|
Aug 22
|
Large employers split on covering GLP-1 drugs for weight loss: Survey
|
Aug 22
|
11 Best Weight Loss Stocks To Invest In
|
Aug 22
|
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
|
Aug 21
|
These 3 Large-Cap Pharma Stocks Have Been Red-Hot
|
Aug 21
|
11 Most Profitable Biotech Stocks Today
|
Jul 22
|
AI Stocks Lead These 5 Names Near Buy Points
|
Jul 22
|
2 Unstoppable Growth Stocks That Could Make You Richer in The Next Decade
|
Jul 22
|
20 Countries With The Highest Rate Of Diabetes
|
Jul 21
|
Ozempic manufacturer Novo Nordisk spent $11 million last year ‘wining and dining’ doctors. Experts slam the move as a breach of doctor-patient trust
|
Jul 21
|
Novo Nordisk Stock Today: This Diagonal Calendar Spread Trade Has Limited Risk, Unlimited Profit Potential
|
Jul 21
|
20 Most Obese States in America in 2023
|
Jul 20
|
IBD Stock Of The Day Novo Nordisk, A Weight-Loss Kingpin, Just Retook Its 50-Day Line
|
Jul 18
|
Novo Nordisk (NVO) Stock Sinks As Market Gains: What You Should Know
|
Jul 18
|
J&J (JNJ) to Begin Q2 Earnings Season for Drug, Biotech Sector
|
Jul 17
|
Is Novo Nordisk a Top Dividend Stock?
|